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Summary
 
To determine the relative contributions of respiratory burst–derived reactive oxygen interme-
diates (ROI) versus reactive nitrogen intermediates (RNI) to macrophage-mediated intracellu-
lar host defense, mice genetically deficient in these mechanisms were challenged with 
 
Leishma-
nia
 
 
 
donovani
 
, a protozoan that selectively parasitizes visceral tissue macrophages. During the
early stage of liver infection at wk 2, both respiratory burst–deficient gp91
 
phox
 
2/2
 
 (X-linked
chronic granulomatous disease [X-CGD]) mice and inducible nitric oxide synthase (iNOS)
knockout (KO) mice displayed comparably increased susceptibility. Thereafter, infection was
unrestrained in mice lacking iNOS but was fully controlled in X-CGD mice. Mononuclear
cell influx into infected liver foci in X-CGD and iNOS KO mice was also overtly impaired at
wk 2. However, granuloma assembly in parasitized tissue eventually developed in both hosts
but with divergent effects: mature granulomas were functionally active (leishmanicidal) in
X-CGD mice but inert in iNOS-deficient animals. These results suggest that (a) ROI and RNI
probably act together in the early stage of intracellular infection to regulate both tissue recruit-
ment of mononuclear inflammatory cells and the initial extent of microbial replication, (b)
RNI alone are necessary and sufficient for eventual control of visceral infection, and (c) al-
though mature granulomas have traditionally been associated with control of such infections,
these structures fail to limit intracellular parasite replication in the absence of iNOS.
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L
 
eishmania
 
 
 
donovani
 
, a protozoan that causes visceral
leishmaniasis, selectively parasitizes and initially repli-
cates within resident macrophages in the liver, spleen and
bone marrow. The host capable of controlling this dissemi-
nated intracellular infection develops an effective T cell–
dependent immune response mediated by proinflammatory,
largely Th1 cell–associated cytokines including IL-12 and
 
IFN-
 
g
 
 (1–3; for review see reference 4). The net effect of
this complex response, which involves granuloma formation
(4, 5), is sufficient activation of both tissue macrophages and
influxing blood monocytes to kill most intracellular 
 
L
 
. 
 
dono-
vani
 
 and induce quiescence in residual infection (4).
In vitro studies suggest that mononuclear phagocytes
possess multiple leishmanicidal mechanisms. Cytokine-acti-
vated mouse peritoneal macrophages kill ingested 
 
L
 
. 
 
dono-
vani
 
 amastigotes by secreting either reactive oxygen inter-
mediates (ROI; primarily H
 
2
 
O
 
2
 
 [6, 7]) or reactive nitrogen
intermediates (RNI; derived from nitric oxide [8]). Inhibit
ing either pathway prevents mouse macrophage killing of
 
L
 
. 
 
donovani
 
 in vitro (6–8); thus, these mechanisms may also
act in concert (9, 10). In cytokine-activated human mono-
cyte-derived macrophages, H
 
2
 
O
 
2
 
 also readily induces leish-
manicidal effects (11); however, a similar role for RNI has
been difficult to detect in cells from normal donors (12). In
vitro–activated human macrophages can also limit 
 
L
 
. 
 
dono-
vani
 
 replication by degrading extracellular tryptophan (13).
Studies carried out to define the macrophage mechanisms
of intracellular 
 
Leishmania
 
 killing in vivo have been more
limited. Thorough observations in a separate mouse model
of 
 
L
 
. 
 
major
 
 cutaneous infection largely (14–17) but not en-
tirely (18, 19) support a critical role for inducible nitric oxide
synthase (iNOS)-generated RNI. RNI are not only leish-
manicidal (8, 14–17) but also regulate immunologic path-
ways, including endogenous secretion of IL-12 and IFN-
 
g
 
(15, 17). In 
 
L
 
. 
 
donovani
 
–infected BALB/c mice, iNOS
mRNA is induced in parasitized tissues (2, 20) and presumed
inhibition of iNOS by aminoguanidine (AG) treatment im-
pairs host defense (2). However, iNOS mRNA induction
(20) and generation of iNOS-derived products in serum and
infected organs (21) do not necessarily correlate with control 
742
 
Reactive Oxygen and Nitrogen Intermediates in Visceral Leishmaniasis
 
over 
 
L
 
. 
 
donovani
 
 (20, 21). In the one published study of para-
sitized tissue in human visceral leishmaniasis, splenic mono-
nuclear phagocytes from each of 22 untreated Indian patients
showed iNOS immunoreactivity (22) (36 
 
6
 
 3% of cells
were iNOS positive; Murray, H., A. Ding, S. Sundar, and
C. Nathan, unpublished data).
To directly compare RNI and ROI as macrophage-
derived antimicrobial mediators in vivo, we used 
 
L
 
. 
 
dono-
vani
 
 to challenge gene-disrupted iNOS knockout (KO)
(23) and respiratory burst–deficient gp91
 
phox
 
2/2
 
 (X-linked
chronic granulomatous disease [X-CGD]) mice (24).
 
Materials and Methods
 
Animals.
 
Mice with a targeted disruption of the gp91
 
phox
 
 sub-
unit of the NADPH-oxidase complex (phox), derived from a
C57BL/6 
 
3 
 
129/Sv background and backcrossed six times with
C57BL/6 mice (24), were provided as breeders by Dr. M.
Dinauer (Indiana University Medical Center, Indianapolis, IN).
C57BL/6 mice (Charles Rivers Labs.) were used as controls.
iNOS
 
2/2
 
 KO mice (C57BL/6 
 
3 
 
129/Sv) were maintained as
originally described (23); wild-type
 
1/1
 
 littermates served as con-
trols. Mice were 8–15 wk old when infected; both males and fe-
males were used randomly except for control C57BL/6 mice (all
female).
 
Visceral Infection and Treatment.
 
Groups of four to five mice
were injected via the tail vein with 1.5 
 
3 
 
10
 
7
 
 hamster spleen–
derived 
 
L
 
. 
 
donovani
 
 amastigotes (1 Sudan strain, provided by Dr.
D. Sacks, National Institutes of Health, Bethesda, MD) (2, 3).
Visceral infection was followed microscopically using Giemsa-
stained liver imprints by counting the number of amastigotes per
500 cell nuclei 
 
3 
 
liver weight (g) (Leishman-Donovan units, or
LDU) (2, 3). Granuloma formation was scored using formalin-
fixed tissue sections stained with hematoxylin and eosin (1–3). In
some experiments, starting 1 d after infection AG (Sigma Chemi-
cal Co.) was added at 1% (wt/vol) to acidified drinking water
changed twice weekly; controls received acidified water alone
(2). Differences between mean values were analyzed by a two-
tailed Student’s 
 
t
 
 test.
 
Results and Discussion
 
Initial Kinetics of Parasite Replication. L
 
. 
 
donovani
 
 repli-
cated in the livers of both strains of control mice during the
first 2 wk after challenge (Fig. 1); thereafter, parasite bur-
dens declined consistent with killing and a self-healing phe-
notype (1). At wk 2, liver burdens in both X-CGD and
iNOS KO mice were significantly higher (by 1.6- and 2.3-
fold, respectively) than in control animals. Since macro-
phages from X-CGD mice produce RNI normally (24)
and macrophages from iNOS KO mice show intact respi-
ratory burst activity (23), the results at wk 2 suggested that
(a) neither mechanism by itself was sufficient to help limit
Figure 1. Course of L. donovani liver infection in (A) X-CGD (s) and
control C57BL/6 mice (d), and in (B) iNOS KO mice (s) and wild-
type controls (d). Results are mean 6 SEM values for 8–15 mice at each
time point from two to four experiments. Asterisk, significantly higher
(P , 0.05) than value in control mice.
 
Table I.
 
Effect of Aminoguanidine Treatment in X-CGD Mice
 
Wk after
infection AG Parasite burden
Percentage of infected
foci showing
granuloma formation
 
LDU
 
2
 
2
 
3,065 
 
6
 
 173 37 
 
6
 
 5
 
1
 
5,214 
 
6
 
 251
 
*
 
9 
 
6
 
 2
 
*
 
4
 
2
 
810 
 
6
 
 146 88 
 
6
 
 10
 
1
 
2,550 
 
6
 
 128
 
*
 
93 
 
6
 
 8
Starting 1 d after 
 
L. donovani
 
 infection, X-CGD mice received acidified
drinking water alone or the same water containing AG at 1% (wt/vol)
for 4 wk. Results indicate mean 
 
6
 
 SEM values from two experiments,
and for liver parasite burdens represent eight mice per group and for
granuloma formation (percentage of liver-infected foci showing devel-
oping or mature granulomas; see Table II) represent six mice per group.
 
*
 
Significantly different (
 
P
 
 
 
,
 
 0.05) from control mice.
 
Table II.
 
Liver Histologic (Granulomatous) Response to
L. donovani Infection in X-CGD and iNOS KO Mice
 
Weeks after infection
X-CGD C57BL/6 iNOS KO
WT
Controls
Tissue reaction 248248248248
None (%) 70 10 0 19 0 0 81 32 1 22 0 0
Granuloma
Developing (%) 29 81 39 78 63 2 19 65 38 57 69 6
Mature (%) 1 9 33 3 37 32 0 3 61 21 31 43
Empty (%) 0 0 28 0 0 66 00000 5 1
All infected foci in 50 consecutive 
 
3
 
63 microscopic fields were scored as
follows for granuloma formation: none, single or fused parasitized Kupffer
cells with no mononuclear cell infiltrate; developing, core of fused in-
fected Kupffer cells with some cell infiltrate; mature, fused Kupffer cell
core surrounded by a well-developed mononuclear cell mantle; and
empty, granuloma devoid of amastigotes (1–4). See Figs. 2 and 3. Results
are from two experiments, and indicate mean values for four to five mice
at each time point. SEM, omitted for clarity, were all 
 
,
 
12%. 
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early 
 
L
 
. 
 
donovani
 
 replication and (b) phox and iNOS may
act in concert to achieve optimal initial activity.
 
Acquired Resistance and Resolution of Infection.
 
After wk 2,
C57BL/6 and wild-type control mice acquired resistance
and showed near-resolution of infection by wk 8 (Fig. 1).
Although initially more susceptible, X-CGD mice also
controlled infection after wk 2 (Fig. 1 A), indicating that
the phox-derived ROI mechanism was dispensable. In
contrast, liver infection was unrestrained in iNOS KO
mice and increased to high levels by wk 8 (Fig. 1 B and see
Fig. 3). Thus, although an intact respiratory burst was nei-
ther required (Fig. 1 A) nor sufficient (Fig. 1 B) for ac-
quired resistance and near-resolution of visceral infection,
these responses were iNOS dependent.
 
Antileishmanial Effect of iNOS in the Absence of Phox.
 
To
determine if the capacity of X-CGD mice to control
 
L
 
. 
 
donovani
 
 infection involved iNOS-derived products, AG
was used as an iNOS inhibitor (2, 25). Continuous AG
treatment enhanced initial susceptibility of X-CGD mice at
wk 2 (Table I), pointing to an active iNOS-dependent
mechanism. At wk 4, liver parasite burdens in AG-treated
X-CGD mice remained elevated; nevertheless, visceral in-
fection began to come under control (Table I). Although
this latter observation raised the possibility of an antimicro-
bial pathway independent of both phox and iNOS and al-
though such pathways exist (9), we did not verify the de-
gree of iNOS inhibition induced by AG. Since iNOS KO
mice failed to control 
 
L
 
. 
 
donovani
 
, incomplete iNOS in-
hibition may well explain the decrease in parasite load at
wk 4 in treated X-CGD animals.
 
Tissue Granulomatous Response.
 
In the liver, acquired
resistance to 
 
L
 
. 
 
donovani
 
 is expressed by a granulomatous
response that encircles all initially parasitized resident mac-
rophages (Kupffer cells) (1–4). This reaction is underway
by wk 2 and fully evident at wk 4 as resistance develops.
The surrounding mantle of the mature leishmanicidal gran-
uloma is formed by influxing T cells and blood monocytes
(4), a process governed by Th1 cell–derived cytokines (2–
4). During resolution of visceral infection (wk 8), the tissue
reaction involutes and most cellular foci are devoid of visi-
ble amastigotes and can be scored as in Table II as micro-
scopically “empty” (5).
Figure 2. Histologic response
to L.  donovani infection in the
liver in X-CGD versus C57BL/6
mice. 2 wk after challenge, gran-
ulomas are developing at in-
fected foci (arrows) in C57BL/6
controls (A); in X-CGD mice
(B), there is little or no reaction
at well-parasitized foci (arrows).
At wk 4, granulomas in C57BL/6
mice (C) in this field are mature
and largely parasite free; (D)
shows developing granulomas in
X-CGD mice. At wk 8, (E)
shows receding granulomas in
C57BL/6 mice, whereas (F) il-
lustrates intense, mature reac-
tion in X-CGD mice. Original
magnification: A and B, 3315;
C–F, 3200. 
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tion already evident at 69–81% of parasitized Kupffer cells
in control mice (Table II and
 
 
 
Figs. 2, A and B, and 3, A
and B). Thus, both phox-derived ROI and iNOS-derived
RNI, presumably acting together, appear to participate in
the early recruitment of T cells and monocytes into in-
fected tissue. This observation further supports the expand-
ing immunoregulatory spectrum of these molecules, partic-
ularly NO (10, 26–28), and in iNOS KO mice may also
The kinetics of the granulomatous response and mature
granuloma assembly were similar in control C57BL/6 (Fig.
2, A, C, and E) and wild-type C57BL/6 3 129/Sv (Fig. 3,
A, C, and E, G) mice (Table II). In contrast, the tissue re-
action in both X-CGD and iNOS KO animals was delayed
and incomplete, particularly at the early stages. At wk 2,
70–81% of infected foci in X-CGD and iNOS KO livers
had failed to attract any of the early mononuclear cell reac-
Figure 3. Histologic response
in livers of infected iNOS KO
mice and wild-type controls. At
wk 2, granulomas are widespread
and developed in controls (A)
but absent at infected foci (ar-
rows) in iNOS KO mice (B). At
wk 4, granulomas are well-estab-
lished or empty in control mice
(C and E); in iNOS KO mice (D
and F), granulomas are develop-
ing but heavily parasitized. At
wk 8, inflammatory reaction in
controls has involuted (G); in
iNOS KO mice (H), granulomas
are well-formed (mature) but
contain numerous replicating
amastigotes (see also Fig. 4).
Original magnification: A, C,
and D, 3200; B and E–H,
3315.745 Murray and Nathan Brief Definitive Report
reflect suppressed induction of IL-12 and IFN-g (17), key
antileishmanial cytokines involved in both mononuclear
cell influx and macrophage activation (2–4).
At wk 4, granuloma formation emerged at 90% of in-
fected sites in X-CGD mice (Fig. 2 D) and at 68% of foci
in iNOS KO mice (Fig. 3, D and F, and Table II). How-
ever, further assembly into mature granulomas (present at
31–37% of foci in control mice; Figs. 2 C and 3, C and E)
was retarded and ,10% of infected foci in either group of
mutant mice could be scored as mature granulomas (Table
II). In X-CGD mice, AG treatment inhibited early granu-
loma assembly (Table I), supporting an active role for
iNOS in the initial tissue response. However, granulomas
developed by wk 4 despite AG treatment, suggesting a
mechanism unrelated to phox or iNOS or suboptimal phar-
macologic inhibition of iNOS.
Results at wk 8 indicated that neither phox nor iNOS
alone was ultimately required for cell recruitment and
assembly, since granulomas developed in both types of de-
ficient mice (Table II). In X-CGD animals, capable of kill-
ing L. donovani, the tissue reaction was widespread, com-
prised of both mature granulomas and inflammatory foci
devoid of parasites (Fig. 2 F), and as in a prior study (29)
was exaggerated at some perivascular areas (data not shown).
However, despite the presence of a similarly well-devel-
oped inflammatory reaction, mature-appearing granulomas
in iNOS-deficient mice contained overwhelming numbers
of replicating amastigotes defining a novel structure, the
“ineffective granuloma” (Figs. 3 H and 4).
Together, these results demonstrate clear-cut, probable
interdigitating roles for both the respiratory burst and en-
dogenous iNOS–derived RNI as macrophage antimicrobial
mechanisms in the initial host defense response to L. dono-
vani. However, the activity of the respiratory burst in in-
flammatory cell recruitment and in limiting intracellular
replication is early and transient, since granulomas formed
and infection resolved in X-CGD mice. Similar findings of
enhanced susceptibility followed by control in X-CGD
mice have been reported in a short-term model of Listeria
monocytogenes infection (30).
It is possible that mechanisms related to neither phox nor
iNOS, such as other sources of ROI and RNI, also emerge
to complete the induction of the tissue cellular immune re-
sponse to L. donovani and contribute additional antileish-
manial effects. However, our results clearly illustrate an
obligatory role for iNOS in intracellular killing in vivo and
resolution of visceral infection. The presence in iNOS-defi-
cient livers of numerous granulomas, well-established but
heavily-laden with intracellular parasites (Fig. 4), graphi-
cally illustrates the tissue consequences of the absence of
this specific macrophage antimicrobial mechanism.
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